BamSEC and AlphaSense Join Forces
Learn More

Astria Therapeutics Inc.

NASDAQ: ATXS    
Share price (1/8/25): $8.35    
Market cap (1/8/25): $471 million

Articles of Incorporation Filter

EX-3.2
from 8-K 27 pages Restated Certificate of Incorporation of Astria Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 22 pages Stockholders
12/34/56
EX-3.3
from 8-K 20 pages Stockholders
12/34/56
EX-3.2
from 8-K 26 pages Restated Certificate of Incorporation of Astria Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 17 pages Catabasis Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 28 pages Stockholders
12/34/56
EX-3.1
from 8-K 11 pages Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc
12/34/56
EX-3.5
from S-1/A 3 pages Certificate of Amendment to Third Amended and Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.4
from S-1 26 pages Stockholders
12/34/56
EX-3.3
from S-1 10 pages Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc
12/34/56
EX-3.2
from S-1 15 pages Stockholders
12/34/56
EX-3.1
from S-1 24 pages Third Amended and Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc
12/34/56
EX-3.4
from DRS/A 26 pages Stockholders
12/34/56
EX-3.2
from DRS 15 pages Stockholders
12/34/56
EX-3.1
from DRS 24 pages Second Amended and Restated Certificate of Incorporation of Catabasis Pharmaceuticals, Inc
12/34/56